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Natural killer (NK) cells are effector lymphocytes of the innate immune system that are 
known for their ability to kill transformed and virus-infected cells. NK cells originate 
from hematopoietic stem cells in the bone marrow, and studies on mouse models have 
revealed that NK cell development is a complex, yet tightly regulated process, which is 
dependent on both intrinsic and extrinsic factors. The development of NK cells can be 
broadly categorized into two phases: lineage commitment and maturation. Efforts to 
better define the developmental framework of NK cells have led to the identification of 
several murine NK progenitor populations and mature NK cell subsets, each defined 
by a varied set of cell surface markers. Nevertheless, the relationship between some 
of these NK cell subsets remains to be determined. The classical approach to studying 
both NK cell development and function is to identify the transcription factors involved 
and elucidate the mechanistic action of each transcription factor. In this regard, recent 
studies have provided further insight into the mechanisms by which transcription factors, 
such as ID2, FOXO1, Kruppel-like factor 2, and GATA-binding protein 3 regulate various 
aspects of NK cell biology. It is also becoming evident that the biology of NK cells is 
not only transcriptionally regulated but also determined by epigenetic alterations and 
posttranscriptional regulation of gene expression by microRNAs. This review summa-
rizes recent progress made in NK development, focusing primarily on transcriptional 
regulators and their mechanistic actions.
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iNTRODUCTiON TO NATURAL KiLLeR (NK) CeLLS
Natural killer cells in mice were first described in 1975 (1–3), following further investigation into 
splenocytes that were able to kill tumor and virus-infected cells without prior sensitization (4–6). 
NK cells exert their cytotoxic effect on target cells by inducing apoptosis. Upon formation of an 
immunological synapse with the target cell, NK cells become activated and release cytolytic granules 
containing perforin and granzymes (7–9). Perforin forms pores in the membrane of target cells, 
thereby allowing granzymes to enter the cell, activate caspases, and initiate apoptosis (8). In a similar 
process known as antibody-dependent cell cytotoxicity, NK cells are able to release cytolytic granules 
and initiate apoptosis in opsonized cells, following recognition of the opsonized cells via low-affinity 
Fc receptors (CD16) expressed on the surface of NK cells (10). NK cells can also initiate apoptosis 
in target cells through the respective engagement of Fas ligands and tumor necrosis factor-related 
apoptosis-inducing ligand (TRAIL) on their cell surface with Fas and TRAIL receptors on the target 
cells (11, 12). In addition to inducing apoptosis, NK cells can indirectly mediate the clearance of 
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target cells by producing pro-inflammatory cytokines [e.g., 
interferon-gamma (IFN-γ)], which boost the innate response and 
recruit adaptive immune responses (13–15).
The surface markers that are commonly used to identify 
murine NK cells by flow cytometry vary depending on the mouse 
strain. C57B/6 and SJL mice express the surface markers NK1.1, 
NKp46, and CD49b, but not CD3, which is a surface marker of T 
cells. CD3 is used to exclude contaminating T cell subsets, such 
as natural killer T cells and NK-like T cells, that, respectively, 
express NK1.1 and NKp46 (16). As for other mouse strains, such 
as BALB/c, NK cells are identified with only CD49b and NKp46 
as these strains possess allelic variants of NK1.1 that cannot be 
detected with the widely used PK136 antibody (16, 17).
MURiNe NK CeLL DeveLOPMeNT
Murine NK cells can be found in all lymphoid organs and many 
non-lymphoid tissues, such as salivary glands, liver, and kidney. 
The more recent discovery of related innate lymphoid cells 
(ILCs) places NK cells within this family, specifically in the IL-15 
dependent, IFN-γ producing group 1 ILCs. ILCs are lymphoid 
cells that lack rearranged antigen receptors and are dependent 
on the transcription factors inhibitor of DNA-binding 2 (ID2) 
and nuclear factor, interleukin 3 regulated (NFIL3) for their 
development. While NK cells are phenotypically heterogene-
ous and previously categorized based on their tissue of origin 
or location (bone marrow, thymus, fetal liver, adult liver), we 
appreciate that some of this heterogeneity stems from NK cells 
(Eomes+) and other ILC1s (Eomes−) being viewed as the same 
cell type. As much of our current understanding of murine NK 
cell development is built upon studies on bone marrow-derived 
NK cells [referred to here as conventional NK (cNK) cells], which 
represent the majority of NK cells within the body, this review 
will focus primarily on progress made in our understanding of 
cNK development.
cNK Development in the Bone  
Marrow—Lineage Commitment
Conventional NK cells develop from HSCs in the bone marrow, 
through a sequential order of intermediate progenitors. The first 
progenitor to arise from HSCs is the lymphoid-primed multipo-
tent progenitor, which then gives rise to the common lymphoid 
progenitor (CLP) (18). The earliest NK lineage committed pro-
genitor to arise from CLPs is known as pre-pro NK (19), which 
was subdivided into pre-pro A and pre-pro B (19, 20). Differing 
only in c-kit (CD117) expression, the relationship between pre-
pro A and B remains unclear and requires further investigation. 
Pre-pro NK cells then differentiate into the NK progenitor (NKP) 
(19, 21). NKPs give rise to immature NK (iNK) cells that either 
undergo further development within the bone marrow (22) or 
enter the periphery and develop into mature NK cells (23, 24).
As the early stages of murine NK development are still poorly 
defined, the developmental pathway outlined above is by no means 
the definitive model. Heterogeneity within existing progenitor 
populations, along with the discovery of new distinguishing cell 
markers, have led to the identification of new sub-populations 
and, therefore, refinements to the developmental pathway of 
NK cells. For instance, the common innate lymphoid progenitor 
(CILP) was found to possess the capacity to give rise to all line-
ages within the ILC family, of which NK cells are the founding 
member, but not B and T cells, thus making it an earlier progeni-
tor than the pre-pro NK (25). As the CILP is expresses α4β7, it is 
also alternatively referred to as the α-lymphoid precursor (αLP) 
(25). However, it has been postulated that there could be an even 
earlier progenitor population, as there were only about 50 CILPs 
per mice, and only 2.5% of CILPs efficiently developed into all 
ILC lineages (25).
The early innate lymphoid progenitor (EILP) is proposed to 
be the earliest known progenitor for ILCs and was identified 
using a TCF1 (T-cell factor 1, encoded by Tcf7) transgenic mouse 
strain that expresses a green fluorescent protein reporter (26). 
Like CILPs, EILPs give rise to all ILC lineages both in vivo and 
in vitro, albeit more efficiently (26). Nonetheless, EILPs have not 
been shown to differentiate into CILPs and hence, the relation-
ship between these two progenitors remains unresolved. As most 
of the surface markers used to identify the EILP and CILP were 
different, a detailed comparison of the surface marker phenotype 
between the two progenitors may also provide further insight.
The discovery of pre–pro NKPs was the outcome of efforts to 
better understand why only 8–40% of NKPs had solely NK cell 
potential (19). Similar studies resulted in the identification of a 
pre-NKP population that preceded a “streamlined” population 
of NKPs known as refined-NKP (rNKP) (27). Even though many 
parallels have been drawn between the pre-NKP and pre-pro 
NK, likewise with NKP and rNKP, it remains to be determined 
if these populations are exactly identical (20). A summary of the 
surface markers that are expressed on the various progenitors are 
provided in Table 1.
cNK Development in the Periphery—NK 
Cell Maturation
Natural killer cell maturation is a process by which lineage com-
mitted NK cells acquire their full effector functions. This process 
is also accompanied by the expression of different cell surface 
markers, which have helped in the identification of different NK 
cell maturation subsets. At present, most studies use CD11b and 
CD27 to divide cNK cells into three maturation subsets: immature 
(Imm), mature 1 (M1), and mature 2 (M2). Low (lo) and high (hi) 
CD11b expression divides cNK cells into immature and mature 
subsets, respectively (22). Heterogeneity in CD27 expression 
further delineates the mature NK compartment into CD27hi and 
CD27lo subsets, which has also been referred to as M1 and M2 NK 
subsets (24, 28). CD27 and CD11b expressing M1 NK cells have 
also been termed double-positive NK cells (24). The three subsets 
differ in proliferative and cytotoxic capacity. In general, NK cells 
lose proliferative potential and produce less cytokine, but become 
more cytotoxic against target cells as they mature (22, 24, 28).
Apart from CD27 and CD11b, markers such as KLRG1 
(23,  29), CD62L (30), MCAM (31), CD49b (21), CD43 (32, 
33), Ly6C (34), DNAM1 (35), and CD160 (36) have further 
dissected maturing NK cells into various phenotypic subsets 
(37, 38). NK cells that express CD160 exhibit enhanced IFN-γ 
TABLe 1 | Surface markers expressed by different natural killer (NK) cell populations reported in the literature.






























NK1.1 − − − − − − − − + + +
CD11b (MAC-1) − − − − − − − − − + +
CD127 (IL-7Rα) hi lo hi hi hi hi hi int int lo lo
CD117 (c-kit) int lo int int lo lo int lo int lo lo
Sca-1 int − int + + + + + − − −
CD49b − − − − − − − − − + +
CD27 + ND + + + + + + + + −
CD244 (2B4) + ND + + + + + + + + +
CD25 (IL-2Rα) − − − ND ND − − + − − −
CD122 (IL-2Rβ) − − − − − + − + + + +
CD132 (IL-2Rγc) + + + + + + + + + + +
CD314 (NKG2D) − − − + + + + + + + +
CD226 (DNAM1) − ND int ND ND + ND ND hi int lo
CD279 (PD1) − ND −/+ ND ND hi ND ND − − −
CD43 (Leukosialin) − − − − − − − − lo int hi
CD335 (NKp46) − − − − − − − − + + +
CD253 (tumor necrosis factor-related 
apoptosis-inducing ligand)
− ND ND ND ND ND ND ND int lo lo
KLRG1 − ND ND − − − ND ND − − +
α4β7 (LPAM) + + + ND ND − ND ND − − −
Ly49s − − − − − − − − −/+ −/+ −/+
CD94-NKG2 − ND ND − − − − − + + +
CD62L (L-selectin) − ND ND − − − ND ND −/+ + +
CD146 (MCAM) − ND ND − − − ND ND lo int hi
CXCR3 − ND ND − − + ND ND hi int lo
CXCR6 − − + + + + ND ND − − −
Ly6C − ND ND − − − ND ND lo int hi
3
Goh and Huntington NK Cell Development
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 130
production (36), while the opposite is true for mature NK cells 
that express higher levels of Ly6C (34), and KLRG1 (39). Like 
Ly6C, MCAM is also more highly expressed on mature NK 
cells, although MCAM+ and MCAM− NK cells differ in their 
ability to kill target cells rather than cytokine production (31). 
Interestingly, the expression of DNAM1 appears to be independ-
ent of NK cell maturation that is defined by CD27 and CD11b, 
as DNAM-1+ and DNAM-1− NK cells were observed in both the 
immature and mature NK compartments (35). As the correla-
tion between these markers have not been studied in detail, the 
relationships between these phenotypic subsets remain unclear 
and warrants further investigation. A summary of the surface 
markers that are expressed on the various mature NK cell subsets 
are provided in Table 1.
TRANSCRiPTiONAL ReGULATiON OF 
MURiNe cNK CeLL DeveLOPMeNT
Transcription factors control gene expression by either activating 
or repressing gene transcription. This is achieved by first binding 
to specific DNA sequences in the enhancer or promoter regions 
that lay upstream of target genes, then promoting or blocking 
the recruitment of RNA polymerases that transcribe those genes 
(40). In terms of murine NK cell development, several TFs have 
been shown to play crucial roles in regulating NK cell lineage 
specification, NK cell maturation, or even both. Conventional 
NK cell development occurs mostly in the bone marrow, under 
the coordinated control of the TFs and cytokines. TFs like ID2, 
NFIL3, T-box brain protein 2 (EOMES), and T-box protein 21 
(TBET) to name a few, fall into the category of intrinsic factors 
that regulate NK cell development. A summary of the tran-
scription factors that are implicated in NK cell development is 
provided in Table 2.
Transcription Factors Regulating NK Cell 
Lineage Specification
The TFs that are involved in regulating NK cell lineage specification 
include ETS proto-oncogene 1 (ETS1), NFIL3, and TCF1. ETS1 
is a key regulator of early NK cell development as ETS1-deficient 
mice have normal CLP numbers but lack NK cells (45). Further 
investigation into the impact of ETS1 deficiency on NK lineage 
specification revealed a reduction in pre-pro NK, pre-NKP and 
TABLe 2 | Transcription factors implicated in natural killer (NK) cell development and function.













Ikaros family zinc finger 3, 
Aiolos (Ikzf3)









KO: normal in vitro killing, 
augmented in vivo killing
B lymphocyte-induced 
maturation protein 1 
(Prdm1)
ND KO: reduced in spleen, liver, and lung; 
accumulation in bone marrow and lymph 
nodes; loss of mNKs
KO: 
hyperresponsive
KO: normal IFN-γ 
production
KO: normal in vitro killing, 
augmented in vivo killing
T-box brain protein 2, 
EOMES (eomesodermin)




ETS proto-oncogene 1, 
ETS1 (Ets1)
KO: lack pre-NKPs 
and rNKPs
KO: reduced KO: 
hyperresponsive
ND KO: impaired in vitro killing 
and degranulation
Forkhead box protein O1, 
FOXO1 (Foxo1)
cKO: normal  
NKP (41)
cKO: reduced; loss of mNKs (41) cKO: 
normal; accumulation of mNKs (42)
ND cKO: augmented 
IFN-γ production 
(42)
cKO: augmented in vitro and 
in vivo killing (42)
GATA-binding protein 3 
(Gata3)
ND cKO: reduced in bone marrow; 
accumulation in spleen and liver, 
systemic accumulation of iNKs




cKO: normal in vitro killing
Inhibitor of DNA-binding 2, 
ID2 (Id2)




KO: impaired IFN-γ 
production
KO: impaired in vitro killing
cKO: normal IFN-γ 
production
cKO: impaired in vivo killing
Interferon Regulatory Factor 
2 (Irf2)
ND KO: reduced; loss of mNKs KO: 
hyporesponsive
KO: impaired IFN-γ 
production
KO: normal in vitro killing (43); 
impaired in vitro killing (44)
Kruppel-like factor 2 (Klf2) ND cKO: reduced in spleen, blood, and lung; 
accumulation in bone marow and liver; 
loss of mNKs
ND ND ND
Myeloid elf-1-like factor 
(Mef)
ND KO: reduced ND KO: impaired IFN-γ 
production
KO: impaired in vitro killing
Nuclear factor, interleukin 3 
regulated, NFIL3 (E4bp4)
KO: lack CILP and 
NKPs, pre-NKPs 
and rNKPs
KO: reduced ND ND ND
T-box protein 21, TBET 
(Tbx21)
ND cKO and KO: reduced in spleen and 
liver; accumulation in bone marrow; loss 
of mNKs
ND KO: impaired IFN-γ 
production
KO: impaired in vitro killing
T-cell-specific transcription 
factor 1, TCF1 (Tcf7)




associated high mobility 
group box protein (Tox)
KO: normal NKP KO: reduced; loss of mNKs ND ND KO: impaired in vivo killing
Zinc finger E-box binding 
homeobox 2 (Zeb2)
ND KO: reduced in periphery; normal in bone 
marrow; loss of mNKs
cKO: 
hyporesponsive
cKO: normal to 
slightly augmented 
IFN-γ production
cKO: impaired killing in vivo
4
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rNKP, and mature NK cell numbers, thereby supporting the role 
of ETS1 in NK cell lineage specification (46). ETS1 is believed 
to impact early NK cell development by regulating the expres-
sion of ID2 and TBET, which are also important TFs for NK cell 
development (46).
TCF1 and NFIL3 are also key regulators of NK cell lineage 
specification, as marked reductions in pre-pro NK, pre-NKP, 
and rNKP numbers were observed within the bone marrow 
of NFIL3- and TCF1-deficient mice, although only the former 
mouse strain exhibited an additional reduction in CILP numbers 
(25, 26, 47, 48). NFIL3 appears to be dispensable for mature NK 
cell as their numbers remained unchanged after its deletion in 
mature NKp46+ NK cells (49). Despite reduced progenitor and 
mature NK cell numbers in the bone marrow of TCF1-deficient 
mice, mature NK cells have been found in the periphery at fre-
quencies comparable to littermate controls (26, 50). As most NK 
cells are derived from bone marrow precursors at steady state, an 
investigation into the source of NK cells in TCF1-deficient mice 
might perhaps shed some light on alternative pathways of NK 
development. The mechanism by which TCF1 mediates NK line-
age specification remains poorly understood. However, TCF1 has 
been shown to regulate T-lineage specification by promoting the 
expression of genes, such as Gata3, Bcl11b, Il2ra, and Cd3e, that 
are critical for T cell development (51). Similarly, the mechanism 
by which NFIL3 specifically mediates lineage specification in NK 
cells remains unclear, although NFIL3 was found to promote the 
expression of ID2 and EOMES (47), transcription factors known 
to be involved in the later stages of NK cell development (52, 53). 
The role of NFIL3 in ID2 expression remains to be clarified given 
a contradicting report that ID2 expression is normal in NK cells 
lacking NFIL3 (48).
The role of ID2 in the lineage specification of NK cells is 
unclear, due to contradicting reports following deletion of the 
encoding gene Id2. While Yokota et  al. (54). reported poor 
reconstitution of NK cells following bone marrow transplanta-
tion, implying a defect early on during NK cell development, 
Boos et al. (55) did not observe any reduction in NKP and iNK 
cell numbers. A recent demonstration of low ID2 levels in CLPs 
but consistently high levels in pre-pro NK, NKP, and immature 
and mature NK cells lends further support for the hypothesis 
that ID2 could indeed be important for NK lineage specification/
maintenance (53). Interestingly, ID2 has been found to suppress 
T and B cell development through heterodimer formation with 
the E-box protein E2A (55–57), although how the interaction 
specifically promotes commitment to the NK cell lineage 
remains unknown.
Transcription Factors Regulating  
NK Cell Maturation
A greater number of TFs have been shown to play a role in NK 
cell maturation. These factors include ID2, TBET, EOMES, Zinc 
finger E-box-binding homeobox 2 (ZEB2), Thymocyte selection-
associated high mobility group box (TOX), IKAROS family zinc 
finger 3 (AIOLOS), Interferon regulatory factor 2 (IRF2), B lym-
phocyte-induced maturation protein 1 (BLIMP1), Forkhead box 
O1 (FOXO1), Kruppel-like factor 2 (KLF2), and GATA-binding 
protein 3 (GATA3). An overview of the expression these TFs 
during NK cell maturation is presented in Figure 1.
The role of ID2 in NK cell maturation is better understood 
than its role in early NK cell development. A recent study pro-
vided additional insight into the underlying mechanism of ID2 
by demonstrating that it modulates the expression of E2A target 
genes (i.e., Socs3, Tcf7, and Cxcr5) by titrating E-protein activity, 
thereby controlling the responsiveness of NK cells to IL-15 that is 
crucial for survival (53, 58, 59).
TBET and EOMES are members of the T-box family of tran-
scription factors that appear to regulate distinct checkpoints in 
NK cell maturation. TBET- and EOMES-deficient mice exhibited 
a similar phenotype where NK cell numbers were reduced in the 
all lymphoid tissues (52, 60, 61), except in the bone marrow of the 
former where there was an increase in NK cell numbers (60, 61). 
Detailed analyses of the bone marrow from TBET-deficient 
mice revealed that the increase in NK cell numbers was due to 
an accumulation of iNK cells, which the authors attributed to a 
developmental block (60). However, the possibility of a defect in 
NK cell trafficking remains unaddressed, given that TBET plays a 
role in the expression of sphigosine-1-phosphate receptor 5 (S1P5) 
that is required for NK cell egression from the bone marrow (62). 
Nonetheless, both TFs are crucial for maturation, as mice that 
are deficient for both have a systemic lack of NK cells despite 
normal progenitor numbers (52, 61). As TBET and EOMES are, 
respectively, required by immature and mature NK cells, the two 
TFs are believed to function in a sequential manner for NK cell 
maturation (52, 60). Quite fittingly, both TBET and EOMES were 
shown to be essential for IL-15 responsiveness by enforcing high 
CD122 expression, with Il2rb (gene encoding CD122) being a 
direct target of EOMES (63).
Similar to that of TBET-deficient mice, NK cell numbers in the 
bone marrow of mice deficient for ZEB2 or BLIMP1 were higher 
than littermate controls (64, 65). The unusual accumulation of 
NK cells within the bone marrow of ZEB2-deficient mice was 
due to reduced S1P5 expression (64), while enhanced prolifera-
tion was found to be the underlying cause in BLIMP1-deficient 
mice (65). Profound losses in terminally mature NK cells were 
observed on closer examination of the bone marrow NK cells 
from both strains (64, 65). The lack of mature NK cells in ZEB2-
deficient was further attributed to poor responsiveness to IL-15, 
which resulted in poor survival (64).
The lack of mature NK cells was reported in mice that were 
deficient for TOX (66), AIOLOS (67), IRF2 (43, 44), KLF2 (68), 
or GATA3 (69, 70). A similar lack of mature NK cells in FOXO1-
deficient mice was reported most recently (41), although this 
remains to be clarified against an earlier study, which instead 
found an accumulation of mature NK cells (42). Interestingly, 
the iNK cells in AIOLOS-deficient mice retained their expres-
sion of KLRG1, which is typically expressed on terminally 
mature NK cells (67). NK cells from IRF2-deficient mice have 
been shown to undergo accelerated apoptosis, indicating a role 
for IRF2 in regulating NK cell survival as well as maturation 
(43). Unlike the foregoing TFs, the temporal requirement for 
myeloid elf-1-like factor (MEF) by maturing NK cells has not 
been determined, as only an overall reduction in NK cell num-
bers was reported (71).
FiGURe 1 | Overview of the early and late stages of natural killer cell development.
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FOXO1 was recently found to be directly involved in the 
initiation of autophagy in iNK cells, most likely via cytosolic 
interactions between FOXO1 and the autophagy protein ATG7 
(41). KLF2 appears to regulate NK cell maturation via a different 
mechanism, influencing the expression of homing receptors such 
as CD62L (i.e., L-selectin) on maturing NK cells, thereby dictating 
their access to IL-15 signaling that is essential for survival (68). 
Current knowledge of how GATA3 regulates NK cell maturation 
is limited to disturbances in expression of the TFs ID2, TBET, 
and NFIL3 (70). Nevertheless, GATA3 has also been shown to 
regulate NK cell egression from the bone marrow in a CXCR4-
dependent manner, and also NK cell proliferation in response to 
IL-15 via CD25 expression (70).
Transcription Factors Regulating  
NK Cell effector Function
Natural killer cell effector function is also regulated by many of 
the TFs outlined above. FOXO1 has also been proposed to nega-
tively regulate NK cell effector function, as its absence was cor-
related with augmented IFN-γ production in response to murine 
cytomegalovirus (MCMV) infections and anti-metastatic activity 
against the B16F10 mouse melanoma cell line (42). Augmented 
anti-metastatic activity against the same melanoma cell line also 
was reported in mice deficient for either BLIMP1 or AIOLOS, 
despite the lack of any significant impact on cytokine production 
(65, 67). On the other hand, MEF is required for normal cytokine 
production and cytotoxicity, as it positively regulates IFN-γ and 
perforin expression, which corresponds to poorer cytotoxicity 
against tumor cell targets in MEF-deficient mice (71). Normal 
cytotoxicity but reduced IFN-γ production has been observed 
in IRF2-deficient mice and mice specifically lacking GATA3 in 
NK cells (43, 70). NK cell function is also regulated by TBET 
and EOMES, as TBET has been shown to bind to the regulatory 
regions of genes encoding granzyme B and perforin, while the 
expression of EOMES as NK cells mature is associated with 
increased transcription of mRNA (52, 60).
POSTTRANSCRiPTiONAL ReGULATiON 
OF NK CeLL DeveLOPMeNT BY 
microRNAs (miRs)
microRNAs are short non-coding RNAs (19–26 nt) that modulate 
gene expression at a posttranscriptional level. Recent studies have 
shown that miRs are also important for NK cell development and 
function. Using a Dicer1-deficient mouse model that abrogates 
miR biogenesis in NK cells, Degouve et al. (72). showed that a 
10-fold global reduction in miR expression resulted in reduced 
NK cell numbers, aberrant NK cell maturation, along with 
attenuated IFN-γ production and cytotoxicity against target cells. 
Given that IL-15 signaling via the STAT5 and mTOR pathways 
was significantly affected, it was proposed that miRs regulate NK 
cell survival by modulating IL-15 sensitivity (72). Although it 
7Goh and Huntington NK Cell Development
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remains unclear as to whether NK cell survival is dependent on 
specific miRs, miR-155 and miR-15/16 are unlikely candidates 
since mice that are deficient for either miR have normal NK cell 
numbers (73, 74).
Rather than NK cell survival, mIR-155 and miR15/16 appear 
to be essential for normal NK cell maturation, as NK cells 
lacking miR-15/16 are unable to fully mature into M2 NK cells 
(74), much like Dicer1-deficient mice, while miR-155-deficient 
NK cells undergo accelerated maturation (73). In contrast to 
the accumulation of M2 NK cells in miR-155 deficient mice, 
an accumulation of Imm NK cells was observed in mice that 
over-expressed miR-155, thereby providing additional evidence 
for the role of miR-155 in NK cell maturation (75). More impor-
tantly, the opposing effect that miR-15/16 and miR-155 have on 
NK cell maturation highlights the pleiotropic effects of miRs and 
suggests that there is still much to learn about the role of miRs 
in NK cell biology, particularly about redundancies between 
miRs. Nevertheless, it has been shown that miR-15/16 controls 
NK maturation by directly regulating levels of the transcription 
factor MYB, since the overexpression of miR-15/16 or MYB defi-
ciency in miR-15/16-deficient NK cells rescues the maturation 
defect (74).
The mechanistic action of miR-155 can be appreciated in the 
context of NK cell proliferation and homeostasis, as NK cells 
deficient for miR-155 were unable to proliferate in response 
to MCMV infections and were also outcompeted by wild-type 
NK cells when cotransferred into homeostatic or lymphopenic 
environments (73). This dependency on miR-155 for prolifera-
tion under both homeostatic and infectious conditions appears 
to be mediated through the direct suppression of its target genes 
suppressor of cytokine signaling 1 (Socs1) and pro-apoptotic 
molecule phorbol-12-myristate-13-acetate-induced protein 1 
(Pmaip1; encoding NOXA) (73). Interestingly, an accumulation 
of NK cells was observed in transgenic mice that over-expressed 
miR-155, lending further support for the regulatory role of miR-
155 in NK cell proliferation (75).
ePiGeNeTiC ReGULATiON OF NK CeLL 
DeveLOPMeNT
Histone modifications have previously been shown to be essential 
events in B and T cell development (76, 77). Recent studies have 
demonstrated that defects in histone modification also impacts 
NK cell development with respect to lineage commitment 
(78) and maturation (79). Mice deficient for enhancer of zeste 
homolog 2 (EZH2), a H3K27 methyltransferase, were observed 
to have higher numbers NKPs and NK cells. Microarray analysis 
revealed that the difference was associated with the upregulation 
of genes essential for NK cell development and function, thereby 
resulting in earlier lineage commitment and enhanced survival of 
NKPs (78). This increase in NK cell production was also observed 
when hematopoietic progenitors from human and wild-type 
mice were treated in vitro with EZH2 inhibitors (78).
A different type of histone modification, deubiquitination, 
also appears to be involved in the epigenetic regulation of NK 
cell maturation. The histone deubiquitinase, MYSM1 (Myb-like, 
SWIRM, and MPN domains-containing protein 1), was found to 
regulate NK cell maturation as MYSM1-deficient mice possessed 
fewer NK cells that were mostly immature (79). Given that no 
defects were observed in the NKP compartment, MYSM1 was 
proposed to be uniquely required during NK cell maturation. 
Mechanistically, MYSM1 regulates NK cell maturation by 
binding directly to the Id2 gene locus, as revealed by chromatin 
immunoprecipitation, thereby maintaining expression of the TF 
(79). However, the mechanism by which MYSM1 is selectively 
directed to the Id2 gene locus remains unclear and thus requires 
further investigation.
CONCLUSiON
The discovery of new members within the ILC family has rekin-
dled efforts to better understand the development of NK cells, 
the founding member of the ILC family. Many of the recent 
breakthroughs made in the transcriptional regulation of NK cell 
development have been aided by key tools and techniques such 
as single cell RNA-seq, in vitro differentiation conditions, tran-
scription factor reporter mice and conditional alleles and lineage 
specific Cre-expressing mouse strains. As these techniques and 
tools become commonplace in the field of NK cell biology, our 
understanding of the temporal–spatial transcriptional regulation 
of NK cell development and the key target genes that govern NK 
cell fate, homeostasis, and function becomes increasingly more 
complete. Recent studies have advanced our understanding of 
how individual TFs may be regulating NK cell commitment and 
NK cell lineage maintenance. However, how these various TFs 
form a transcriptional network and act in concert to ensure NK 
cell homeostasis remains unclear.
On a translational front, defining the extrinsic cues and 
TFs that regulate NK cell maturation, proliferation, cytokine 
responsiveness, and priming of effector functions represents an 
area of therapeutic interest. Proteins that negatively regulate NK 
cell maturation and fitness are tangible drug targets in cancer 
immunotherapy as recently evidenced by our group. Building on 
these potential targets will increase the likelihood of developing 
specific inhibitors for clinical translation.
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